Pradžia › LOPSL › Texas › Dallas

LOPSL klinikiniai tyrimai Dallas, TX

12 tyrimai dėl LOPSL ieško dalyvių vietose Dallas ir aplinkui (apytiksliai 30 mylių spinduliu). Atidarykite tyrimą, kad pamatytumėte, kas gali dalyvauti ir kaip susisiekti su tyrimo komanda.

Oficialus tyrimo tekstas (anglų kalba)

Ieškote dalyvių tyrimui? Pateikite jį šio puslapio viršuje – $99 už 30 dienų →

A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease

Renkami dalyviai3 fazė

Research Site, Dallas

Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-02 · NCT06283966

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype

Renkami dalyviai3 fazė

IntraCare- Site Number : 8400034, Dallas

Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-10-01 · NCT07190222

Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype

Renkami dalyviai3 fazė

Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas

Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-22 · NCT07190209

An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema

Renkami dalyviai

University of Texas Southwestern, Dallas

Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-17 · NCT06035120

A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Renkami dalyviai2 fazė

Research Site, Dallas

Amžius 40 ir vyresni · Visoms lytims · Atnaujinta 2026-09-09 · NCT07082738

A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)

Renkami dalyviai3 fazė

Research Site, Dallas

Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-09-03 · NCT06883305

A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease

Renkami dalyviai2/3 fazė

Alina Clinical Trials, LLC., Dallas

Amžius nuo 35 iki 80 · Visoms lytims · Atnaujinta 2026-08-31 · NCT07363694

A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)

Renkami dalyviai3 fazė

GC2501 Study Site 109, Dallas

Amžius nuo 18 iki 80 · Visoms lytims · Atnaujinta 2026-08-11 · NCT07555483

STRIVE Post-Market Registry Study

Renkami dalyviaiStebimasis tyrimas

Baylor Scott & White Research Institute, Dallas
University of Texas Southwestern, Dallas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-08-03 · NCT04302272

eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation

Renkami dalyviai3 fazė

GSK Investigational Site, Dallas

Amžius nuo 40 iki 75 · Visoms lytims · Atnaujinta 2026-07-28 · NCT07177339

Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Renkami dalyviaiStebimasis tyrimas

Liver Center of Texas, Dallas

Amžius 18 ir vyresni · Visoms lytims · Atnaujinta 2026-07-10 · NCT05181826

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Renkami dalyviai3 fazė

GSK Investigational Site, Dallas

Amžius nuo 40 iki 80 · Visoms lytims · Atnaujinta 2026-04-09 · NCT06961214

LOPSL tyrimai kituose miestuose

Kiti tyrimai Dallas

Iš ClinicalTrials.gov, duomenys gauti 2026-10-04. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.